The present invention relates to the administration of compositions comprising an antiestrogen, preferably trans -clomiphene, for treating metabolic syndrome in a subject. The invention is also directed to methods for reducing fasting glucose levels in a subject by administering a composition comprising an antiestrogen, preferably trans -clomiphene.